Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) Enterprise Value (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Enterprise Value for 16 consecutive years, with -$5.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Enterprise Value rose 41.71% to -$5.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.0 million, a 41.71% increase, with the full-year FY2024 number at -$5.5 million, up 14.66% from a year prior.
  • Enterprise Value was -$5.0 million for Q3 2025 at GeoVax Labs, down from -$3.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$768859.0 in Q1 2024 to a low of -$34.7 million in Q3 2022.
  • A 5-year average of -$14.3 million and a median of -$12.7 million in 2023 define the central range for Enterprise Value.
  • Peak YoY movement for Enterprise Value: tumbled 9296.81% in 2021, then skyrocketed 96.78% in 2024.
  • GeoVax Labs' Enterprise Value stood at -$11.4 million in 2021, then tumbled by 141.71% to -$27.6 million in 2022, then skyrocketed by 76.63% to -$6.5 million in 2023, then grew by 14.66% to -$5.5 million in 2024, then increased by 9.04% to -$5.0 million in 2025.
  • Per Business Quant, the three most recent readings for GOVX's Enterprise Value are -$5.0 million (Q3 2025), -$3.1 million (Q2 2025), and -$7.4 million (Q1 2025).